JP2021520811A5 - - Google Patents
Info
- Publication number
- JP2021520811A5 JP2021520811A5 JP2020555467A JP2020555467A JP2021520811A5 JP 2021520811 A5 JP2021520811 A5 JP 2021520811A5 JP 2020555467 A JP2020555467 A JP 2020555467A JP 2020555467 A JP2020555467 A JP 2020555467A JP 2021520811 A5 JP2021520811 A5 JP 2021520811A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- isolated nucleic
- promoter
- acid construct
- itr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862657243P | 2018-04-13 | 2018-04-13 | |
| US62/657,243 | 2018-04-13 | ||
| PCT/US2019/027271 WO2019200286A1 (en) | 2018-04-13 | 2019-04-12 | Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021520811A JP2021520811A (ja) | 2021-08-26 |
| JP2021520811A5 true JP2021520811A5 (cg-RX-API-DMAC7.html) | 2022-04-18 |
Family
ID=68163786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555467A Withdrawn JP2021520811A (ja) | 2018-04-13 | 2019-04-12 | ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックaavベクターならびにその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12486518B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3773748A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021520811A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112203697A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020020836A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3096102A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019200286A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3285788B1 (en) | 2015-04-23 | 2024-12-18 | University of Massachusetts | Modulation of aav vector transgene expression |
| CA3115251A1 (en) | 2018-10-05 | 2020-04-09 | University Of Massachusetts | Raav vectors for the treatment of gm1 and gm2 gangliosidosis |
| CN115279421A (zh) * | 2020-01-10 | 2022-11-01 | 坚固生物科技公司 | 用于联合疗法的病毒载体 |
| EP4472657A4 (en) * | 2022-02-04 | 2026-02-18 | M6P Therapeutics Inc | COMPOSITIONS AND METHODS OF USE OF A TWO-PROMOTER VECTOR FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS |
| KR20250158063A (ko) * | 2023-03-16 | 2025-11-05 | 젠자임 코포레이션 | 건식 연령-관련 황반 변성의 치료 |
| WO2026064462A1 (en) * | 2024-09-18 | 2026-03-26 | Genzyme Corporation | Production of recombinant aav |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5217865A (en) | 1986-07-25 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Screening for Tay-Sachs disease with cloned DNA for beta-hexosaminidase |
| DE69334238D1 (de) | 1992-09-25 | 2008-09-25 | Aventis Pharma Sa | Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn |
| US6346415B1 (en) | 1997-10-21 | 2002-02-12 | Targeted Genetics Corporation | Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors |
| IL141403A0 (en) | 1998-08-28 | 2002-03-10 | Univ Duke | Deleted adenoviruses and methods of making and administering the same |
| AU2013202568B2 (en) | 2001-11-13 | 2015-09-17 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus rh.8 (AAVrh.8) sequences and recombinant AAVs comprising same |
| CN1429905A (zh) * | 2002-01-04 | 2003-07-16 | 北京大学 | 治疗帕金森病的可调控双基因表达的重组腺病毒伴随病毒载体 |
| US7858367B2 (en) | 2002-04-30 | 2010-12-28 | Duke University | Viral vectors and methods for producing and using the same |
| ATE446077T1 (de) | 2002-05-02 | 2009-11-15 | Univ Rochester | Vektoren mit beiden isoformen von beta- hexosaminidase |
| US20040192630A1 (en) | 2002-05-02 | 2004-09-30 | Stephanos Kyrkanides | Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| JP4979067B2 (ja) | 2003-05-01 | 2012-07-18 | ジェンザイム・コーポレーション | 神経代謝性疾患についての遺伝子治療 |
| PL2158322T3 (pl) | 2007-06-06 | 2017-10-31 | Genzyme Corp | Terapia genowa dla lizosomalnych chorób spichrzeniowych |
| CN102203622A (zh) | 2008-09-04 | 2011-09-28 | 加利尼公司 | 突触小泡循环的测定和系统 |
| AU2010316982B2 (en) | 2009-11-09 | 2013-09-12 | Genepod Therapeutics Ab | Novel viral vector construct for neuron specific continuous DOPA synthesis in vivo |
| WO2011062298A1 (ja) | 2009-11-19 | 2011-05-26 | 国立大学法人岡山大学 | 遺伝子発現を上昇させるシステム及び該システムを保持したベクター |
| US20130090374A1 (en) | 2011-04-20 | 2013-04-11 | Miguel Sena-Esteves | Methods for the treatment of tay-sachs disease, sandhoff disease, and gm1-gangliosidosis |
| AU2012272815B2 (en) | 2011-06-22 | 2017-09-07 | The General Hospital Corporation | Treatment of proteinopathies |
| EP2910632B1 (en) | 2012-10-19 | 2017-07-05 | Tokushima University | Highly functional enzyme having modified substrate specificity of human beta-hexosaminidase b and exhibiting protease resistance |
| JP2016523835A (ja) | 2013-05-15 | 2016-08-12 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 中枢神経系へのアデノ随伴ウイルスを介した遺伝子導入 |
| WO2015060722A1 (en) | 2013-10-24 | 2015-04-30 | Uniqure Ip B.V. | Aav-5 pseudotyped vector for gene therapy for neurological diseases |
| EP3119892B1 (en) | 2014-03-17 | 2021-03-10 | The Hospital For Sick Children | Beta-hexosaminidase protein variants and associated methods for treating gm2 gangliosdoses |
| EA201791803A1 (ru) | 2015-02-10 | 2017-11-30 | Джензим Корпорейшн | Улучшенная доставка вирусных частиц в полосатое тело и кору больших полушарий |
| EP3285788B1 (en) | 2015-04-23 | 2024-12-18 | University of Massachusetts | Modulation of aav vector transgene expression |
| US10016514B2 (en) | 2015-05-15 | 2018-07-10 | New Hope Research Foundation | Polynucleotides, vectors and methods for insertion and expression of transgenes |
| CA3011939A1 (en) | 2016-02-02 | 2017-08-10 | University Of Massachusetts | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system |
| US11045557B2 (en) | 2016-06-09 | 2021-06-29 | Queen's University At Kingston | Methods and gene therapy constructs for treating GM2 gangliosidoses |
| WO2019222314A1 (en) | 2018-05-15 | 2019-11-21 | University Of Massachusetts | Raav vectors encoding of lysosomal beta-galactorsidase (glb1) and cathepsin a |
| CA3115251A1 (en) | 2018-10-05 | 2020-04-09 | University Of Massachusetts | Raav vectors for the treatment of gm1 and gm2 gangliosidosis |
-
2019
- 2019-04-12 WO PCT/US2019/027271 patent/WO2019200286A1/en not_active Ceased
- 2019-04-12 JP JP2020555467A patent/JP2021520811A/ja not_active Withdrawn
- 2019-04-12 EP EP19784280.0A patent/EP3773748A4/en not_active Withdrawn
- 2019-04-12 BR BR112020020836-1A patent/BR112020020836A2/pt not_active IP Right Cessation
- 2019-04-12 CN CN201980034667.4A patent/CN112203697A/zh active Pending
- 2019-04-12 CA CA3096102A patent/CA3096102A1/en active Pending
- 2019-04-12 US US17/046,756 patent/US12486518B2/en active Active
-
2025
- 2025-10-30 US US19/374,990 patent/US20260049336A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260139274A1 (en) | Gene therapy for juvenile batten disease | |
| US20220364117A1 (en) | Adeno-Associated Virus Vector Delivery of Muscle Specific Micro-Dystrophin To Treat Muscular Dystrophy | |
| JP2022508182A5 (cg-RX-API-DMAC7.html) | ||
| JP7208133B2 (ja) | 酸性αグルコシダーゼ変異体及びその使用 | |
| JP2018520646A (ja) | ファブリー病の遺伝子治療 | |
| US20230272422A1 (en) | Adeno-associated viral vector for glut1 expression and uses thereof | |
| JP7541027B2 (ja) | 筋肉発現のためのハイブリッドプロモーター | |
| RU2018116076A (ru) | Модифицированные гены атаксии фридрейха и векторы для генной терапии | |
| JP2022523679A5 (cg-RX-API-DMAC7.html) | ||
| JP2021533805A5 (cg-RX-API-DMAC7.html) | ||
| KR20250102136A (ko) | 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법 | |
| CN114144518A (zh) | 用于基因疗法的双亮氨酸拉链激酶抑制剂 | |
| JP2023522883A (ja) | 神経学的障害を処置するための組成物および方法 | |
| US20240376493A1 (en) | Optimized ap4m1 polyneucleotides and expression cassettes and their use | |
| CN113891712A (zh) | 用于晚期婴儿神经元蜡样脂褐质沉积症2型的aav载体治疗方法 | |
| US20220049270A1 (en) | Transgene cassettes, aav vectors, and aav viral vectors for expression of human codon-optimized cstb | |
| US20240342314A1 (en) | Slc13a5 gene therapy vectors and uses thereof | |
| US12480098B1 (en) | Adeno-associated virus variant | |
| TWI883636B (zh) | 含有星狀細胞導向啟動子構築體之合成核酸及其使用方法 | |
| WO2024163335A2 (en) | Pten gene therapy vectors and uses thereof | |
| WO2023102518A1 (en) | Gnao1 gene therapy vectors and uses thereof | |
| WO2022272056A2 (en) | Compositions and methods for treating pgm1 deficiency | |
| RU2022111695A (ru) | Выделенная нуклеиновая кислота, которая кодирует слитый белок на основе FVIII-BDD и гетерологичного сигнального пептида, и ее применение | |
| TH2201002179A (th) | แคสเสตการถ่ายโอน aav |